Sclerostin and bone strength in women in their 10th decade of life
Journal of Bone and Mineral Research, 03/18/2013Thorson S et al.
Sclerostin is a potent inhibitor of bone formation but has been shown to correlate positively with areal bone mineral density (aBMD). Little is known about its relationship to parameters of bone strength and volumentric BMD (vBMD) as measured by peripheral quantitative computed tomography (pQCT). The results suggest paradoxical associations between circulating sclerostin and bone size, density and strength.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.